Access the full text.
Sign up today, get DeepDyve free for 14 days.
Using poly(lactic acid) (PLA) as biodegradable and biocompatible material is demanded for vascular scaffolds especially a susceptible substitute of permanent metal stents in treatment of coronary heart disease. In this work, PLA nanofibers containing aspirin (Asp) loaded into zeolitic imidazolate framework nanoparticles (ZIF-8@Asp NPs) were prepared for vascular tissue application. In this line, ZIF-8@Asp NPs were synthesized, and their characterization revealed their average NP size and the drug loading efficiency of approximately 180 nm and 76 %. Afterward, ZIF-8@Asp NPs were loaded into PLA nanofibers and the obtained results showed a uniform morphology with an average nanofibers diameter of around 544 nm, Young’s modulus of 1.7 MPa, and the ultimate drug release of 19 % after six days. Besides degradation studies of the sample, the addition of ZIF-8@Asp NPs to the PLA nanofibers displayed no adverse effect on the shape recovery properties. Finally, the hemolysis and platelet adhesion confirmed that the surface of the ZIF-8@Asp-loaded PLA nanofibrous samples exhibited appropriate hemocompatibility.
Fibers and Polymers – Springer Journals
Published: Aug 1, 2022
Keywords: PLA; ZIF-8; Aspirin; Nanofiber; Platelet
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.